13-valent pneumococcal conjugate vaccine pcv13 prevenar 13 (Pfizer Inc)
90
Structured Review
Pfizer Inc
13-valent pneumococcal conjugate vaccine pcv13 prevenar 13
13 Valent Pneumococcal Conjugate Vaccine Pcv13 Prevenar 13, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcv13+prevenar+13/pcv13/pmc12152759-90-11-18
Average 90 stars, based on 1 article reviews
13 Valent Pneumococcal Conjugate Vaccine Pcv13 Prevenar 13, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcv13+prevenar+13/pcv13/pmc12152759-90-11-18
Average 90 stars, based on 1 article reviews
13-valent pneumococcal conjugate vaccine pcv13 prevenar 13 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Mouse Assay:Article Title: Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis. Article Snippet: Article Title: Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience Article Snippet: Furthermore, the pneumococcal vaccines employed were Article Title: Low Pneumococcal Vaccination among Patients with Psoriasis in Germany: Results from Vac-Pso Article Snippet: Immunocompromised patients should receive a sequential Article Title: Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A Phase I study (V114-028) Article Snippet: Article Title: Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis Article Snippet: The PCVs included in the review xx NIHR Journals Library www.journalslibrary.nihr.ac.uk SCIENTIFIC SUMMARY were Article Title: Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy. Article Snippet: Article Title: Pneumococcal nasopharyngeal carriage among Bhutanese children hospitalized with clinical pneumonia: serotypes and viral co-infection Article Snippet: Currently, there are two Article Title: Bifidobacteria support optimal infant vaccine responses. Article Snippet: Infants were vaccinated with Vaccines:Article Title: Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis. Article Snippet: Article Title: Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience Article Snippet: Furthermore, the pneumococcal vaccines employed were Article Title: Low Pneumococcal Vaccination among Patients with Psoriasis in Germany: Results from Vac-Pso Article Snippet: Immunocompromised patients should receive a sequential Article Title: Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A Phase I study (V114-028) Article Snippet: Article Title: Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis Article Snippet: The PCVs included in the review xx NIHR Journals Library www.journalslibrary.nihr.ac.uk SCIENTIFIC SUMMARY were Article Title: Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy. Article Snippet: Article Title: Pneumococcal nasopharyngeal carriage among Bhutanese children hospitalized with clinical pneumonia: serotypes and viral co-infection Article Snippet: Currently, there are two Article Title: Bifidobacteria support optimal infant vaccine responses. Article Snippet: Infants were vaccinated with Injection:Article Title: Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis. Article Snippet: Article Title: Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience Article Snippet: Furthermore, the pneumococcal vaccines employed were Article Title: Low Pneumococcal Vaccination among Patients with Psoriasis in Germany: Results from Vac-Pso Article Snippet: Immunocompromised patients should receive a sequential Article Title: Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A Phase I study (V114-028) Article Snippet: Article Title: Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis Article Snippet: The PCVs included in the review xx NIHR Journals Library www.journalslibrary.nihr.ac.uk SCIENTIFIC SUMMARY were Article Title: Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy. Article Snippet: Article Title: Pneumococcal nasopharyngeal carriage among Bhutanese children hospitalized with clinical pneumonia: serotypes and viral co-infection Article Snippet: Currently, there are two Article Title: Bifidobacteria support optimal infant vaccine responses. Article Snippet: Infants were vaccinated with Purification:Article Title: Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis. Article Snippet: Article Title: Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience Article Snippet: Furthermore, the pneumococcal vaccines employed were Article Title: Low Pneumococcal Vaccination among Patients with Psoriasis in Germany: Results from Vac-Pso Article Snippet: Immunocompromised patients should receive a sequential Article Title: Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A Phase I study (V114-028) Article Snippet: Article Title: Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis Article Snippet: The PCVs included in the review xx NIHR Journals Library www.journalslibrary.nihr.ac.uk SCIENTIFIC SUMMARY were Article Title: Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy. Article Snippet: Article Title: Pneumococcal nasopharyngeal carriage among Bhutanese children hospitalized with clinical pneumonia: serotypes and viral co-infection Article Snippet: Currently, there are two Article Title: Bifidobacteria support optimal infant vaccine responses. Article Snippet: Infants were vaccinated with Variant Assay:Article Title: Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis. Article Snippet: Article Title: Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience Article Snippet: Furthermore, the pneumococcal vaccines employed were Article Title: Low Pneumococcal Vaccination among Patients with Psoriasis in Germany: Results from Vac-Pso Article Snippet: Immunocompromised patients should receive a sequential Article Title: Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A Phase I study (V114-028) Article Snippet: Article Title: Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis Article Snippet: The PCVs included in the review xx NIHR Journals Library www.journalslibrary.nihr.ac.uk SCIENTIFIC SUMMARY were Article Title: Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy. Article Snippet: Article Title: Pneumococcal nasopharyngeal carriage among Bhutanese children hospitalized with clinical pneumonia: serotypes and viral co-infection Article Snippet: Currently, there are two Article Title: Bifidobacteria support optimal infant vaccine responses. Article Snippet: Infants were vaccinated with |